|
|
|
·ÎƼ¹ÌºêÁ¤10/10mg Rotimibe Tab. 10/10mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
³ë¶õ»öÀÇ Àå¹æÇü Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
Çö´ë¾àÇ°(ÁÖ)
|
ÆǸÅȸ»ç |
Çö´ë¾àÇ°(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2016.02.29)
|
BIT ¾àÈ¿ºÐ·ù |
°íÁöÇ÷Áõ Ä¡·áÁ¦ (Antilipidemic Agents)
|
º¹ÁöºÎºÐ·ù |
218[µ¿¸Æ°æÈ¿ëÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
642003760 \1,063 ¿ø/1Á¤(2023.09.05)(ÇöÀç¾à°¡)\1,251 ¿ø/1Á¤(2017.02.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
rosuvastatin and ezetimibe / C10BA06 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
¶ó¿ì¸±È²»ê³ªÆ®·ý,
¹«¼öÀλê¼ö¼ÒÄ®½·,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
À¯´ç¼öȹ°,
Å©·Î½ºÄ«¸£¸á·Î¿À½º³ªÆ®·ý,
Å©·Î½ºÆ÷ºñµ·,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-04-25 |
|
|
|
|
|
|
|
|